APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Type Hard Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-animal Type Hard Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchNon-animal Type Hard Capsules Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Type Hard Capsules Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Non-animal Type Hard Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Type Hard Capsules Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Type Hard Capsules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Non-animal Type Hard Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-animal Type Hard Capsules include Lonza, Hunan Er-Kang Pharmaceutical Co., Ltd, Sunil Healthcare, Roxlor, Qualicaps (Mitsubishi Chemical), Procaps S.A, Pharco, Patheon (Banner Pharmacaps) and Medicaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-animal Type Hard Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-animal Type Hard Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-animal Type Hard Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-animal Type Hard Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-animal Type Hard Capsules Segment by Company

Lonza

Hunan Er-Kang Pharmaceutical Co., Ltd

Sunil Healthcare

Roxlor

Qualicaps (Mitsubishi Chemical)

Procaps S.A

Pharco

Patheon (Banner Pharmacaps)

Medicaps

Jedco International Pharmaceutical

JC Biological Technology

Catalent

CapsCanada

Bahrain Pharma

Arab-Caps

Aenova

ACPL

ACG Associated Capsules

Non-animal Type Hard Capsules Segment by Type

Type I

00E

0E

Non-animal Type Hard Capsules Segment by Application

Pharmaceutical

Nutraceutical

Cosmetics

Non-animal Type Hard Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Type Hard Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Type Hard Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Type Hard Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-animal Type Hard Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-animal Type Hard Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-animal Type Hard Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-animal Type Hard Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-animal Type Hard Capsules Industry Trends Table 2. Non-animal Type Hard Capsules Industry Drivers Table 3. Non-animal Type Hard Capsules Industry Opportunities and Challenges Table 4. Non-animal Type Hard Capsules Industry Restraints Table 5. Global Non-animal Type Hard Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-animal Type Hard Capsules Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers Table 9. Global Non-animal Type Hard Capsules Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Non-animal Type Hard Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-animal Type Hard Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-animal Type Hard Capsules Manufacturers, Product Type & Application Table 13. Global Non-animal Type Hard Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-animal Type Hard Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Type I Table 17. Major Manufacturers of 00E Table 18. Major Manufacturers of 0E Table 19. Global Non-animal Type Hard Capsules Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 21. Global Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 22. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2026) Table 23. Global Non-animal Type Hard Capsules Sales Market Share by Type (2027-2032) Table 24. Global Non-animal Type Hard Capsules Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (k units) Table 26. Global Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (k units) Table 27. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2026) Table 28. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceutical Table 30. Major Manufacturers of Nutraceutical Table 31. Major Manufacturers of Cosmetics Table 32. Global Non-animal Type Hard Capsules Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 34. Global Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 35. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2026) Table 36. Global Non-animal Type Hard Capsules Sales Market Share by Application (2027-2032) Table 37. Global Non-animal Type Hard Capsules Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (k units) Table 39. Global Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (k units) Table 40. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2026) Table 41. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2027-2032) Table 42. Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Non-animal Type Hard Capsules Sales by Region (2021-2026) & (k units) Table 44. Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2026) Table 45. Global Non-animal Type Hard Capsules Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Non-animal Type Hard Capsules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 49. North America Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 50. Europe Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 52. Europe Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 59. Global Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Non-animal Type Hard Capsules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Non-animal Type Hard Capsules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2026) Table 63. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2027-2032) Table 64. Lonza Company Information Table 65. Lonza Business Overview Table 66. Lonza Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Lonza Non-animal Type Hard Capsules Product Portfolio Table 68. Lonza Recent Development Table 69. Hunan Er-Kang Pharmaceutical Co., Ltd Company Information Table 70. Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview Table 71. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio Table 73. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Development Table 74. Sunil Healthcare Company Information Table 75. Sunil Healthcare Business Overview Table 76. Sunil Healthcare Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio Table 78. Sunil Healthcare Recent Development Table 79. Roxlor Company Information Table 80. Roxlor Business Overview Table 81. Roxlor Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Roxlor Non-animal Type Hard Capsules Product Portfolio Table 83. Roxlor Recent Development Table 84. Qualicaps (Mitsubishi Chemical) Company Information Table 85. Qualicaps (Mitsubishi Chemical) Business Overview Table 86. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio Table 88. Qualicaps (Mitsubishi Chemical) Recent Development Table 89. Procaps S.A Company Information Table 90. Procaps S.A Business Overview Table 91. Procaps S.A Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Procaps S.A Non-animal Type Hard Capsules Product Portfolio Table 93. Procaps S.A Recent Development Table 94. Pharco Company Information Table 95. Pharco Business Overview Table 96. Pharco Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Pharco Non-animal Type Hard Capsules Product Portfolio Table 98. Pharco Recent Development Table 99. Patheon (Banner Pharmacaps) Company Information Table 100. Patheon (Banner Pharmacaps) Business Overview Table 101. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio Table 103. Patheon (Banner Pharmacaps) Recent Development Table 104. Medicaps Company Information Table 105. Medicaps Business Overview Table 106. Medicaps Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Medicaps Non-animal Type Hard Capsules Product Portfolio Table 108. Medicaps Recent Development Table 109. Jedco International Pharmaceutical Company Information Table 110. Jedco International Pharmaceutical Business Overview Table 111. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio Table 113. Jedco International Pharmaceutical Recent Development Table 114. JC Biological Technology Company Information Table 115. JC Biological Technology Business Overview Table 116. JC Biological Technology Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. JC Biological Technology Non-animal Type Hard Capsules Product Portfolio Table 118. JC Biological Technology Recent Development Table 119. Catalent Company Information Table 120. Catalent Business Overview Table 121. Catalent Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Catalent Non-animal Type Hard Capsules Product Portfolio Table 123. Catalent Recent Development Table 124. CapsCanada Company Information Table 125. CapsCanada Business Overview Table 126. CapsCanada Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. CapsCanada Non-animal Type Hard Capsules Product Portfolio Table 128. CapsCanada Recent Development Table 129. Bahrain Pharma Company Information Table 130. Bahrain Pharma Business Overview Table 131. Bahrain Pharma Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio Table 133. Bahrain Pharma Recent Development Table 134. Arab-Caps Company Information Table 135. Arab-Caps Business Overview Table 136. Arab-Caps Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Arab-Caps Non-animal Type Hard Capsules Product Portfolio Table 138. Arab-Caps Recent Development Table 139. Aenova Company Information Table 140. Aenova Business Overview Table 141. Aenova Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Aenova Non-animal Type Hard Capsules Product Portfolio Table 143. Aenova Recent Development Table 144. ACPL Company Information Table 145. ACPL Business Overview Table 146. ACPL Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. ACPL Non-animal Type Hard Capsules Product Portfolio Table 148. ACPL Recent Development Table 149. ACG Associated Capsules Company Information Table 150. ACG Associated Capsules Business Overview Table 151. ACG Associated Capsules Non-animal Type Hard Capsules Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio Table 153. ACG Associated Capsules Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Non-animal Type Hard Capsules Distributors List Table 157. Non-animal Type Hard Capsules Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Non-animal Type Hard Capsules Product Image Figure 2. Global Non-animal Type Hard Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-animal Type Hard Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-animal Type Hard Capsules Sales (2021-2032) & (k units) Figure 5. Global Non-animal Type Hard Capsules Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-animal Type Hard Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Type I Image Figure 9. 00E Image Figure 10. 0E Image Figure 11. Global Non-animal Type Hard Capsules Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Non-animal Type Hard Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032) Figure 14. Global Non-animal Type Hard Capsules Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Non-animal Type Hard Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Nutraceutical Image Figure 19. Cosmetics Image Figure 20. Global Non-animal Type Hard Capsules Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Non-animal Type Hard Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032) Figure 23. Global Non-animal Type Hard Capsules Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Non-animal Type Hard Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032) Figure 26. North America Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 28. U.S. Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 33. Germany Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 40. China Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 48. Brazil Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Non-animal Type Hard Capsules Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Non-animal Type Hard Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Non-animal Type Hard Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Figure 59. North America Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Europe Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Non-animal Type Hard Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Non-animal Type Hard Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • 00E
  • 0E
Applications
  • Pharmaceutical
  • Nutraceutical
  • Cosmetics
Companies covered
  • Lonza
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Sunil Healthcare
  • Roxlor
  • Qualicaps (Mitsubishi Chemical)
  • Procaps S.A
  • Pharco
  • Patheon (Banner Pharmacaps)
  • Medicaps
  • Jedco International Pharmaceutical
  • JC Biological Technology
  • Catalent
  • CapsCanada
  • Bahrain Pharma
  • Arab-Caps
  • Aenova
  • ACPL
  • ACG Associated Capsules

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-animal Type Hard Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-animal Type Hard Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-animal Type Hard Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-animal Type Hard Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-animal Type Hard Capsules Market Dynamics
  1. 2.1 Non-animal Type Hard Capsules Industry Trends
  2. 2.2 Non-animal Type Hard Capsules Industry Drivers
  3. 2.3 Non-animal Type Hard Capsules Industry Opportunities and Challenges
  4. 2.4 Non-animal Type Hard Capsules Industry Restraints
3 Non-animal Type Hard Capsules Market by Manufacturers
  1. 3.1 Global Non-animal Type Hard Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-animal Type Hard Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-animal Type Hard Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-animal Type Hard Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-animal Type Hard Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-animal Type Hard Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Non-animal Type Hard Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-animal Type Hard Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-animal Type Hard Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-animal Type Hard Capsules Tier 1, Tier 2, and Tier 3
4 Non-animal Type Hard Capsules Market by Type
  1. 4.1 Non-animal Type Hard Capsules Type Introduction
  2. 4.1.1 Type I
  3. 4.1.2 00E
  4. 4.1.3 0E
  5. 4.2 Global Non-animal Type Hard Capsules Sales by Type
  6. 4.2.1 Global Non-animal Type Hard Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-animal Type Hard Capsules Sales by Type (2021-2032)
  8. 4.2.3 Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032)
  9. 4.3 Global Non-animal Type Hard Capsules Revenue by Type
  10. 4.3.1 Global Non-animal Type Hard Capsules Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  12. 4.3.3 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032)
5 Non-animal Type Hard Capsules Market by Application
  1. 5.1 Non-animal Type Hard Capsules Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Nutraceutical
  4. 5.1.3 Cosmetics
  5. 5.2 Global Non-animal Type Hard Capsules Sales by Application
  6. 5.2.1 Global Non-animal Type Hard Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-animal Type Hard Capsules Revenue by Application
  10. 5.3.1 Global Non-animal Type Hard Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032)
6 Global Non-animal Type Hard Capsules Sales by Region
  1. 6.1 Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-animal Type Hard Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Non-animal Type Hard Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Non-animal Type Hard Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-animal Type Hard Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-animal Type Hard Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-animal Type Hard Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-animal Type Hard Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-animal Type Hard Capsules Revenue by Region
  1. 7.1 Global Non-animal Type Hard Capsules Revenue by Region
  2. 7.1.1 Global Non-animal Type Hard Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-animal Type Hard Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-animal Type Hard Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-animal Type Hard Capsules Revenue (2021-2032)
  8. 7.2.2 North America Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-animal Type Hard Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-animal Type Hard Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-animal Type Hard Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-animal Type Hard Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Hunan Er-Kang Pharmaceutical Co., Ltd
  8. 8.2.1 Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
  9. 8.2.2 Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview
  10. 8.2.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
  12. 8.2.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
  13. 8.3 Sunil Healthcare
  14. 8.3.1 Sunil Healthcare Company Information
  15. 8.3.2 Sunil Healthcare Business Overview
  16. 8.3.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
  18. 8.3.5 Sunil Healthcare Recent Developments
  19. 8.4 Roxlor
  20. 8.4.1 Roxlor Company Information
  21. 8.4.2 Roxlor Business Overview
  22. 8.4.3 Roxlor Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
  24. 8.4.5 Roxlor Recent Developments
  25. 8.5 Qualicaps (Mitsubishi Chemical)
  26. 8.5.1 Qualicaps (Mitsubishi Chemical) Company Information
  27. 8.5.2 Qualicaps (Mitsubishi Chemical) Business Overview
  28. 8.5.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
  30. 8.5.5 Qualicaps (Mitsubishi Chemical) Recent Developments
  31. 8.6 Procaps S.A
  32. 8.6.1 Procaps S.A Company Information
  33. 8.6.2 Procaps S.A Business Overview
  34. 8.6.3 Procaps S.A Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
  36. 8.6.5 Procaps S.A Recent Developments
  37. 8.7 Pharco
  38. 8.7.1 Pharco Company Information
  39. 8.7.2 Pharco Business Overview
  40. 8.7.3 Pharco Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharco Non-animal Type Hard Capsules Product Portfolio
  42. 8.7.5 Pharco Recent Developments
  43. 8.8 Patheon (Banner Pharmacaps)
  44. 8.8.1 Patheon (Banner Pharmacaps) Company Information
  45. 8.8.2 Patheon (Banner Pharmacaps) Business Overview
  46. 8.8.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
  48. 8.8.5 Patheon (Banner Pharmacaps) Recent Developments
  49. 8.9 Medicaps
  50. 8.9.1 Medicaps Company Information
  51. 8.9.2 Medicaps Business Overview
  52. 8.9.3 Medicaps Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
  54. 8.9.5 Medicaps Recent Developments
  55. 8.10 Jedco International Pharmaceutical
  56. 8.10.1 Jedco International Pharmaceutical Company Information
  57. 8.10.2 Jedco International Pharmaceutical Business Overview
  58. 8.10.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
  60. 8.10.5 Jedco International Pharmaceutical Recent Developments
  61. 8.11 JC Biological Technology
  62. 8.11.1 JC Biological Technology Company Information
  63. 8.11.2 JC Biological Technology Business Overview
  64. 8.11.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
  66. 8.11.5 JC Biological Technology Recent Developments
  67. 8.12 Catalent
  68. 8.12.1 Catalent Company Information
  69. 8.12.2 Catalent Business Overview
  70. 8.12.3 Catalent Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Catalent Non-animal Type Hard Capsules Product Portfolio
  72. 8.12.5 Catalent Recent Developments
  73. 8.13 CapsCanada
  74. 8.13.1 CapsCanada Company Information
  75. 8.13.2 CapsCanada Business Overview
  76. 8.13.3 CapsCanada Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
  78. 8.13.5 CapsCanada Recent Developments
  79. 8.14 Bahrain Pharma
  80. 8.14.1 Bahrain Pharma Company Information
  81. 8.14.2 Bahrain Pharma Business Overview
  82. 8.14.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
  84. 8.14.5 Bahrain Pharma Recent Developments
  85. 8.15 Arab-Caps
  86. 8.15.1 Arab-Caps Company Information
  87. 8.15.2 Arab-Caps Business Overview
  88. 8.15.3 Arab-Caps Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
  90. 8.15.5 Arab-Caps Recent Developments
  91. 8.16 Aenova
  92. 8.16.1 Aenova Company Information
  93. 8.16.2 Aenova Business Overview
  94. 8.16.3 Aenova Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aenova Non-animal Type Hard Capsules Product Portfolio
  96. 8.16.5 Aenova Recent Developments
  97. 8.17 ACPL
  98. 8.17.1 ACPL Company Information
  99. 8.17.2 ACPL Business Overview
  100. 8.17.3 ACPL Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ACPL Non-animal Type Hard Capsules Product Portfolio
  102. 8.17.5 ACPL Recent Developments
  103. 8.18 ACG Associated Capsules
  104. 8.18.1 ACG Associated Capsules Company Information
  105. 8.18.2 ACG Associated Capsules Business Overview
  106. 8.18.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
  108. 8.18.5 ACG Associated Capsules Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-animal Type Hard Capsules Value Chain Analysis
  2. 9.1.1 Non-animal Type Hard Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-animal Type Hard Capsules Production Mode & Process
  6. 9.2 Non-animal Type Hard Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-animal Type Hard Capsules Distributors
  9. 9.2.3 Non-animal Type Hard Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst